Safety and Efficacy of ARQ-154 Foam in Adolescent and Adult Subjects With Scalp and Body Psoriasis
Public ClinicalTrials.gov record NCT04128007. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, 8-Week, Parallel Group, Double Blind, Vehicle-Controlled Study of the Safety and Efficacy of ARQ-154 Foam 0.3% Administered QD in Adolescents and Adults With Scalp and Body Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will assess the safety and efficacy of ARQ-154 foam vs placebo applied once a day for 56 days by subjects with scalp and body psoriasis
Study identification
- NCT ID
- NCT04128007
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 304 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 13, 2020 (Actual)
- Primary completion
- Sep 23, 2020 (Actual)
- Completion
- Sep 25, 2020 (Actual)
- Last update posted
- Oct 26, 2022
2020
United States locations
- U.S. sites
- 31
- U.S. states
- 18
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arcutis Biotherapeutics Clinical Site 71 | Rogers | Arkansas | 72758 | — |
| Arcutis Biotherapeutics Clinical Site 72 | Fremont | California | 94538 | — |
| Arcutis Biotherapeutics Clinical Site 85 | San Diego | California | 92123 | — |
| Arcutis Biotherapeutics Clinical Site 21 | Cromwell | Connecticut | 06416 | — |
| Arcutis Biotherapeutics Clinical Site 91 | Boynton Beach | Florida | 33437 | — |
| Arcutis Biotherapeutics Clinical Site 20 | Coral Gables | Florida | 33134 | — |
| Arcutis Biotherapeutics Clinical Site 88 | Miami | Florida | 33144 | — |
| Arcutis Biotherapeutics Clinical Site 90 | Miami | Florida | 33714 | — |
| Arcutis Biotherapeutics Clinical Site 83 | Sweetwater | Florida | 33172 | — |
| Arcutis Biotherapeutics Clinical Site 99 | Rolling Meadows | Illinois | 60008 | — |
| Arcutis Biotherapeutics Clinical Site 78 | Indianapolis | Indiana | 46250 | — |
| Arcutis Biotherapeutics Clinical Site 95 | Plainfield | Indiana | 46168 | — |
| Arcutis Biotherapeutics Clinical Site 77 | Louisville | Kentucky | 40217 | — |
| Arcutis Biotherapeutics Clinical Site 79 | Covington | Louisiana | 70433 | — |
| Arcutis Biotherapeutics Clinical Site 94 | Metairie | Louisiana | 70006 | — |
| Arcutis Biotherapeutics Clinical Site 73 | Fridley | Minnesota | 55432 | — |
| Arcutis Biotherapeutics Clinical Site 84 | Saint Joseph | Missouri | 64506 | — |
| Arcutis Biotherapeutics Clinical Site 98 | Portsmouth | New Hampshire | 03801 | — |
| Arcutis Biotherapeutics Clinical Site 87 | High Point | North Carolina | 27262 | — |
| Arcutis Biotherapeutics Clinical Site 96 | Bexley | Ohio | 43209 | — |
| Arcutis Biotherapeutics Clinical Site 82 | Portland | Oregon | 97210 | — |
| Arcutis Biotherapeutics Clinical Site 80 | Broomall | Pennsylvania | 19008 | — |
| Arcutis Biotherapeutics Clinical Site 97 | Murfreesboro | Tennessee | 37130 | — |
| Arcutis Biotherapeutics Site 70 | Arlington | Texas | 76011 | — |
| Arcutis Biotherapeutics Clinical Site 76 | Austin | Texas | 78759 | — |
| Arcutis Biotherapeutics Clinical Site 86 | College Station | Texas | 77845 | — |
| Arcutis Biotherapeutics Clinical Site 74 | Houston | Texas | 77056 | — |
| Arcutis Biotherapeutics Clinical Site 89 | Pflugerville | Texas | 78660 | — |
| Arcutis Biotherapeutics Clinical Site 93 | San Antonio | Texas | 78213 | — |
| Arcutis Biotherapeutics Clinical Site 81 | Norfolk | Virginia | 23502 | — |
| Arcutis Biotherapeutics Clinical Site 75 | Richmond | Virginia | 23220 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04128007, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 26, 2022 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04128007 live on ClinicalTrials.gov.